)
Humacyte (HUMA) investor relations material
Humacyte AGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Opening remarks and agenda
Meeting commenced virtually with executive management, board members, and legal counsel present.
Voting procedures and eligibility were outlined, with polls open during the meeting.
Rules of conduct and question submission process were explained for stockholders.
Board and executive committee updates
Introduction of director nominees John P. Bamforth, Keith Anthony Jones, and Kathleen Sebelius for election as Class II directors until the 2029 annual meeting.
Board unanimously recommended voting in favor of all director nominees and proposals.
Shareholder proposals
Advisory vote on executive compensation and frequency of future Say-on-Pay votes presented.
Proposal to ratify PricewaterhouseCoopers LLP as independent auditor for 2026.
Proposal to amend certificate of incorporation to increase authorized common stock from 350 million to 550 million shares.
- Symvess sales rose, net loss widened, restructuring cut costs, and global expansion progressed.HUMA
Q1 202613 May 2026 - 2025 revenue grew to $2.0M, net loss narrowed, and major clinical and commercial milestones achieved.HUMA
Q4 20251 May 2026 - ATEV outperformed AV fistula in women with ESKD, reducing catheter dependence and complications.HUMA
KOL event30 Apr 2026 - Shareholders will vote on director elections, executive pay, auditor ratification, and increasing authorized shares.HUMA
Proxy filing28 Apr 2026 - Board recommends approval of all proposals, including director elections and share increase.HUMA
Proxy filing17 Apr 2026 - Strong clinical data and strategic partnerships drive expansion into trauma, dialysis, and coronary markets.HUMA
Barclays 28th Annual Global Healthcare Conference10 Mar 2026 - Engineered vessel platform shows clinical, economic, and pipeline momentum across major indications.HUMA
TD Cowen 46th Annual Health Care Conference4 Mar 2026 - SYMVESS launch targets trauma centers with strong clinical data and a robust cash runway through 2026.HUMA
H.C. Wainwright 3rd Annual BioConnect Investor Conference 20253 Feb 2026 - Engineered vessels show superior outcomes in trauma, with FDA decision expected in August.HUMA
Jefferies 2024 Global Healthcare Conference1 Feb 2026
Next Humacyte earnings date
Next Humacyte earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)